Mission
TO PROVIDE PREVENTIVE AND TREATMENT SERVICES ACROSS THE SPECTRUM OF KIDNEY DISEASE; CONDUCT BASIC AND CLINICAL RESEARCH IN RENAL AND CARDIOVASCULAR DISEASES, DIABETES, CANCER, OUTCOME RESEARCH AND POLICY FORMULATION.
Public Charity
The Rogosin Institute Inc
The Rogosin Institute Inc is a nonprofit organization categorized as Public Charity based in New York, NY. Its most recent IRS filing (2024) reports revenue of $122.8M, expenses of $122.0M, total assets of $111.8M. Imperigo tracks 54 reported grant relationships connected to this organization totaling approximately $7.8M.
EIN: 133184198
New York, NY
Research Institutes & Public Policy Analysis
NTEE: E05
Latest filing: 2024
Total Revenue$122.8M
Total Expenses$122.0M
Total Assets$111.8M
Grant Records54
Funding Total$7.8M
Filing Years2019–2024
Where $100 goes at The Rogosin Institute Inc
How The Rogosin Institute Inc divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
$79
Programs
the work itself
$20
Management
running the organization
$1
Fundraising
raising the next dollar
Inside the $79 for programs
$61
DIALYSIS FACILITY
$13
Immunogenetics and transplatation center
$3
RESEARCH
Plus 1 more program. Cost per person served and the full program breakdown are on the full profile.
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
GENERAL SUPPORT
$10,000
Research subaward
$170,003
MEDICAL/SCIENTIFIC RESEARCH & PROGRAMS
$100,000
Research
$51,218
Care Center Grant
$28,000
Showing up to 5 of 54 total records — full history available with membership.
Officers & Directors
PHYSICIAN
Alan S Perlman
EVP/COO
Allyson Z Pifko
PHYSICIAN
Andrew Bohmart
DIRECTOR (THRU 6/2024)
Anne Alexis Cote Taylor
DIRECTOR
Brian K Regan
EVP/CLINICAL SERVICE & STRATEGY (THRU 3/2024)
Bruce R Gordon
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $122.8M | $122.0M | $111.8M |
| 2023 | $118.4M | $122.7M | $116.8M |
| 2022 | $116.5M | $123.9M | $117.9M |
| 2020 | $114.2M | $118.8M | $90.4M |
| 2019 | $110.9M | $114.2M | $84.0M |
Between 2019 and 2024, reported annual revenue grew from $110.9M to $122.8M (+11%), with total assets most recently reported at $111.8M.
Interactive year-over-year charts and full filing details available with membership.